Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

October
23
2017

Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radio Therapy & Post-Treatment Care

Collaboration Brings Sensus Healthcare’s SRT Technology and Stratpharma’s Wound Care Medical Devices Together to Advance Radiation Patient Outcomes SAN DIEGO, Oct. 23, 2017 — Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss…

October
16
2017

John Berry & Friends All Come Together for Hurricane Relief

John Berry & Friends All Come Together for Hurricane Relief!

October
11
2017

Sensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference

BOCA RATON, Fla., Oct. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), today announced that management…

October
09
2017

Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting

BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announced today that an…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy